Research from WorldCare Consortium® member Dana-Farber Cancer Institute indicates blood test’s potential for early detection of lung cancer
A study led by doctors at WorldCare Consortium® member Dana-Farber Cancer Institute has found that a test analyzing free-floating DNA in the blood may be able to detect early-stage lung cancer. A preliminary report from the on-going Circulating Cell-Free Genome Atlas (CCGA) study, which is one of the first studies to explore whether sequencing blood-borne DNA is […]